NCT06655493

Levels of Inflammation in Middle East People With Cardiovascular Disease With/Without Kidney Disease

A Cross-sectional Study to Investigate Prevalence of Systemic Inflammation (hsCRP) in Cohort of Patients With HF and a Cohort of Patients With ASCVD and CKD in the Middle East

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 756 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease) with/without kidney disease. The aim of the study is to assess the number of people with high levels of systemic inflammation among Middle East people with cardiovascular with/without kidney disease. Systemic inflammation means that it occurs throughout the body. Participation in this study only requires a single visit at the clinic/hospital/medical institution. Participants will continue their normal care and will not get any treatment as part of this study.

Conditions

• Systemic Inflammation (hsCRP)

Interventions

Type	Name	Description
OTHER	No treatment given	Participants will continue their normal care and will not get any treatment as part of this study.

Timeline

• Start date: 2024-11-22
• Primary completion: 2025-08-28
• Completion: 2025-08-28
• First posted: 2024-10-23
• Last updated: 2025-10-21

Locations

20 sites across 2 countries: Saudi Arabia, United Arab Emirates